Nuvectis Pharma's total assets for Q2 2024 were $18.28M, a decrease of -7.26% from the previous quarter. NVCT total liabilities were $5.77M for the fiscal quarter, a 1.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.